Table 2. Features of study groups.
| All patients (n=30) | Non-sacroiliitis group (n=19) | Active sacroiliitis group (n=6) | ||||
| n | Mean±SD | n | Mean±SD | n | Mean±SD | |
| Age (year) | 44.1±12.5 | 45.1±13.1 | 46.5±8.5 | |||
| Sex | ||||||
| Male | 2 | 2 | 0 | |||
| Female | 28 | 17 | 6 | |||
| Disease duration (year) | 5.9±3.9 | 6.8±4.5 | 4.3±1.5 | |||
| Inflammatory back pain | 8* | 1 | 5t | |||
| Human leukocyte antigen B27 | 4** | 1 positive | 2 positive | |||
| (17 studied) | (10 studied) | (4 studied) | ||||
| Diagnostic sacroiliitis radiogram | 6t | None | 4 | |||
| C-reactive protein (mg/L) | 6.7±3.6 | 5.6±3.0 | 10.5±4.0t | |||
| SD: Standard deviation; * Two patients in chronic sacroiliitis group; ** One patient in chronic sacroiliitis group (three studied); † Two patients in chronic sacroiliitis group; ‡ p<0.05 compared to non-sacroiliitis group. | ||||||